Cover Image
市場調查報告書

高藥理活性原料藥 (HPAPI)的全球市場預測 2021年:合成HPAPI、生物科技HPAPI

High Potency API /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech (Biologic, Biosimilar)), Manufacturer (Captive, Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecast to 2021

出版商 MarketsandMarkets 商品編碼 544749
出版日期 內容資訊 英文 216 Pages
訂單完成後即時交付
價格
Back to Top
高藥理活性原料藥 (HPAPI)的全球市場預測 2021年:合成HPAPI、生物科技HPAPI High Potency API /HPAPI Market by Type (Innovative, Generic), Synthesis (Synthetic, Biotech (Biologic, Biosimilar)), Manufacturer (Captive, Merchant), Therapy (Oncology, Glaucoma, Hormonal Imbalance) - Global Forecast to 2021
出版日期: 2017年01月12日 內容資訊: 英文 216 Pages
簡介

全球高藥理活性原料藥 (HPAPI) 市場規模,預計從2016年的160億2,000萬美元,到2021年達到240億9,000萬美元,從2016年到2021年以8.5%的年複合成長率成長。

本報告以全球高藥理活性原料藥 (HPAPI) 市場為研究主題,提供各種類、合成型、治療領域,及各地區的市場統計與分析,市場成長的影響因素分析,及主要企業簡介等資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 高藥理活性原料藥 (HPAPI) 市場概要
  • 高藥理活性原料藥 (HPAPI) 市場:各類型
  • 高藥理活性原料藥 (HPAPI) 市場:各合成型
  • 高藥理活性原料藥 (HPAPI) 市場:各治療領域
  • 高藥理活性原料藥 (HPAPI) 市場:各地區的概要

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進要素
    • 抑制因素
    • 機會
    • 課題

第6章 高藥理活性原料藥 (HPAPI)的分類、概要

  • 簡介
  • 高藥理活性原料藥 (HPAPI)的分類:自SAFEBRIDGE CONSULTANTS

第7章 高藥理活性原料藥 (HPAPI) 市場:各類型

  • 簡介
  • 創新的HPAPI
  • 非專利HPAPI

第8章 高藥理活性原料藥 (HPAPI) 市場:各合成型

  • 簡介
  • 合成HPAPI
  • 生物科技HPAPI

第9章 高藥理活性原料藥 (HPAPI) 市場:製造商的各類型

  • 簡介
  • CAPTIVE製造商
  • MERCHANT製造商
    • 各類型
    • 各合成型

第10章 高藥理活性原料藥 (HPAPI) 市場:各治療應用領域

  • 簡介
  • 癌症
  • 荷爾蒙失調
  • 青光眼
  • 其他治療應用

第11章 高藥理活性原料藥 (HPAPI) 市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞洲
  • 其他 (RoW)

第12章 競爭情形

  • 概要
  • 市場佔有率分析
  • 競爭情形、趨勢

第13章 企業簡介

  • 簡介
  • PFIZER, INC.
  • NOVARTIS INTERNATIONAL AG
  • SANOFI
  • F. HOFFMANN-LA ROCHE LTD.
  • BRISTOL-MYERS SQUIBB
  • BOEHRINGER INGELHEIM
  • TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • ELI LILLY AND COMPANY
  • MERCK & CO., INC.
  • ABBVIE INC.
  • MYLAN N.V.

第14章 附錄

目錄
Product Code: PH 4897

The global high potency active pharmaceutical ingredients (HPAPI) market is expected to reach USD 24.09 billion by 2021 from USD 16.02 billion in 2016, growing at a CAGR of 8.5% from 2016 to 2021. This market is categorized on the basis of type, type of manufacturer, type of synthesis, therapeutic application, and region.

Major factors contributing to the growth of the high potency rapid growth in the oncology drugs market, increasing focus of pharmaceutical companies on HPAPIs, and advancements in HPAPI technologies. Growing demand for antibody drug conjugates also provide an impetus for the growth of this market. Their high specificity of action, has caused ACDs to gain significant attention, resulting in a noteworthy increase in the number of ADCs under development. Considering the growing opportunities in this market, many companies are making significant investments for the development of novel ACDs. In October 2015, ADC Biotechnology (U.K.) invested USD 10 million to build a manufacturing facility for advanced anticancer drugs. Many companies are also cross collaborating for research in the development of next-generation ADCs. For example, in June 2014, Merck Serono entered into a collaboration with Mersana Therapeutics Inc. for the development of next-generation ADCs.

Emerging markets have opened an array of opportunities for the high potency active pharmaceutical ingredients market. Moreover, the market also offers lucrative opportunities for CMOs and CDMOs. However, factors such as a stringent regulatory requirements and requirement of large investments may restrain the growth of this market.

Based on type, the market is segmented into innovative and generic HPAPIs. On the basis of type of manufacture, the HPAPIs market is categorized into two segments, captive manufacturer and merchant manufacturer. On the basis of type of synthesis, the HPAPIs market is segmented into synthetic HPAPIs and biotech HPAPIs. On the basis of therapeutic application, the HPAPIs market is further segmented into oncology, hormonal disorders, glaucoma, and other therapeutic applications.

Research Coverage:

Apart from the comprehensive geographical and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views on key players in the active pharmaceutical ingredients market and their product portfolios, developments, and strategies. The above-mentioned market research data, current market size, and forecast of the future trends will help key players and new entrants to make the necessary decisions regarding product offerings, geographical focus, changes in strategic approach, R&D investments for innovations in products and technologies, and levels of output in order to remain successful.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of top players in the active pharmaceutical ingredients market. The report analyzes the active pharmaceutical ingredients market by application, sales channel, and region
  • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and new product launches in the active pharmaceutical ingredients market
  • Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of leading players in the active pharmaceutical ingredients market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various active pharmaceutical ingredients products across geographies
  • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the active pharmaceutical ingredients market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. STUDY SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. MARKET STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. MARKET SIZE ESTIMATION
  • 2.2. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.3. KEY DATA FROM SECONDARY SOURCES
  • 2.4. INSIGHTS FROM PRIMARY SOURCES
  • 2.5. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET OVERVIEW
  • 4.2. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
  • 4.3. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS
  • 4.4. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC AREA
  • 4.5. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: GEOGRAPHIC SNAPSHOT

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rapid growth in the oncology drugs market
      • 5.2.1.2. Growing demand for antibody drug conjugates
      • 5.2.1.3. Increasing focus of leading pharmaceutical companies on HPAPIs
      • 5.2.1.4. Advancements in HPAPI manufacturing technologies
    • 5.2.2. RESTRAINTS
      • 5.2.2.1. Stringent regulatory requirements
      • 5.2.2.2. Requirement of large investments
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Growing opportunities for CMOs and CDMOs
      • 5.2.3.2. Emerging markets
    • 5.2.4. CHALLENGES
      • 5.2.4.1. Stringent safety and handling specifications
      • 5.2.4.2. Uncertainty associated with products
      • 5.2.4.3. Need for appropriate process design
      • 5.2.4.4. Constant evolution of industry standards and technologies

6. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS CLASSIFICATION AND OVERVIEW

  • 6.1. INTRODUCTION
  • 6.2. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS CLASSIFICATION AS PER SAFEBRIDGE CONSULTANTS

7. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
  • 7.3. GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS

8. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS

  • 8.1. INTRODUCTION
  • 8.2. SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
    • 8.2.1. SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
      • 8.2.1.1. Innovative synthetic HPAPIs
      • 8.2.1.2. Generic synthetic HPAPIs
  • 8.3. BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS
    • 8.3.1. BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE
      • 8.3.1.1. Innovative biotech HPAPIs
      • 8.3.1.2. Biosimilars

9. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF MANUFACTURER

  • 9.1. INTRODUCTION
  • 9.2. CAPTIVE MANUFACTURERS
  • 9.3. MERCHANT MANUFACTURERS
    • 9.3.1. MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE
      • 9.3.1.1. Innovative merchant HPAPI manufacturers
      • 9.3.1.2. Generic merchant HPAPI manufacturers
    • 9.3.2. MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS
      • 9.3.2.1. Synthetic HPAPIs
      • 9.3.2.2. Biotech HPAPIs

10. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION

  • 10.1. INTRODUCTION
  • 10.2. ONCOLOGY
  • 10.3. HORMONAL IMBALANCE
  • 10.4. GLAUCOMA
  • 10.5. OTHER THERAPEUTIC APPLICATIONS

11. HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION

  • 11.1. INTRODUCTION
  • 11.2. NORTH AMERICA
    • 11.2.1. U.S.
    • 11.2.2. CANADA
  • 11.3. EUROPE
    • 11.3.1. GERMANY
    • 11.3.2. FRANCE
    • 11.3.3. U.K.
    • 11.3.4. ITALY
    • 11.3.5. SPAIN
    • 11.3.6. REST OF EUROPE (ROE)
  • 11.4. ASIA
    • 11.4.1. JAPAN
    • 11.4.2. CHINA
    • 11.4.3. INDIA
    • 11.4.4. REST OF ASIA (ROA)
  • 11.5. REST OF THE WORLD (ROW)

12. COMPETITIVE LANDSCAPE

  • 12.1. OVERVIEW
  • 12.2. MARKET SHARE ANALYSIS
  • 12.3. COMPETITIVE SITUATION AND TRENDS
    • 12.3.1. AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND ALLIANCES
    • 12.3.2. MERGERS AND ACQUISITIONS
    • 12.3.3. REGULATORY APPROVALS
    • 12.3.4. EXPANSIONS

13. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 13.1. INTRODUCTION
  • 13.2. PFIZER, INC.
  • 13.3. NOVARTIS INTERNATIONAL AG
  • 13.4. SANOFI
  • 13.5. F. HOFFMANN-LA ROCHE LTD.
  • 13.6. BRISTOL-MYERS SQUIBB
  • 13.7. BOEHRINGER INGELHEIM
  • 13.8. TEVA PHARMACEUTICAL INDUSTRIES LTD.
  • 13.9. ELI LILLY AND COMPANY
  • 13.10. MERCK & CO., INC.
  • 13.11. ABBVIE INC.
  • 13.12. MYLAN N.V.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

14. APPENDIX

  • 14.1. INSIGHTS FROM INDUSTRY EXPERTS
  • 14.2. DISCUSSION GUIDE
  • 14.3. OTHER DEVELOPMENTS
  • 14.4. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.5. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 14.6. AVAILABLE CUSTOMIZATIONS
  • 14.7. RELATED REPORTS
  • 14.8. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: RAPIDLY GROWING ONCOLOGY DRUGS SEGMENT: A MAJOR MARKET DRIVER
  • TABLE 2: STRINGENT REGULATORY REQUIREMENTS: A MAJOR RESTRAINT FOR MARKET GROWTH
  • TABLE 3: EMERGING MARKETS TO OFFER POTENTIAL GROWTH OPPORTUNITIES
  • TABLE 4: STRINGENT SAFETY AND HANDLING SPECIFICATIONS: A MAJOR CHALLENGE FOR MARKET GROWTH
  • TABLE 5: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 6: INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: NORTH AMERICA: INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 8: EUROPE: INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: ASIA: INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 10: GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: NORTH AMERICA: GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 12: EUROPE: GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 13: ASIA: GENERIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF SYNTHESIS 2014-2021 (USD MILLION)
  • TABLE 15: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: NORTH AMERICA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 17: EUROPE: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 18: ASIA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 19: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 20: INNOVATIVE SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: NORTH AMERICA: INNOVATIVE SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 22: EUROPE: INNOVATIVE SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 23: ASIA: INNOVATIVE SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 24: GENERIC SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: NORTH AMERICA: GENERIC SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 26: EUROPE: GENERIC SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 27: ASIA: GENERIC SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 28: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: NORTH AMERICA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 30: EUROPE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 31: ASIA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 32: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 33: INNOVATIVE BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: NORTH AMERICA: INNOVATIVE BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 35: EUROPE: INNOVATIVE BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: ASIA: INNOVATIVE BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: BIOSIMILARS MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: NORTH AMERICA: BIOSIMILARS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 39: EUROPE: BIOSIMILARS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: ASIA: BIOSIMILARS INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 41: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 42: CAPTIVE HPAPI MANUFACTURERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: CAPTIVE HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: EUROPE: CAPTIVE HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 45: ASIA: CAPTIVE HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 46: MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: EUROPE: MERCHANT HPAPI MANUFACTURER MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 49: ASIA: MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 50: GLOBAL MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE, 2014-2021, (USD MILLION)
  • TABLE 51: INNOVATIVE MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 52: NORTH AMERICA: INNOVATIVE MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 53: EUROPE: INNOVATIVE MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 54: ASIA: INNOVATIVE MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 55: GENERIC MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 56: NORTH AMERICA: GENERIC MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 57: EUROPE: GENERIC MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 58: ASIA: GENERIC MERCHANT HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 59: GLOBAL MERCHANT HPAPI MANUFACTURERS MARKET, BY TYPE OF SYNTHESIS, 2014-2021, (USD MILLION)
  • TABLE 60: MERCHANT SYNTHETIC HPAPI MANUFACTURERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 61: NORTH AMERICA: MERCHANT SYNTHETIC HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 62: EUROPE: MERCHANT SYNTHETIC HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 63: ASIA: MERCHANT SYNTHETIC HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 64: MERCHANT BIOTECH HPAPI MANUFACTURERS MARKET, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 65: NORTH AMERICA: MERCHANT BIOTECH HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 66: EUROPE: MERCHANT BIOTECH HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 67: ASIA: MERCHANT BIOTECH HPAPI MANUFACTURERS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 68: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 69: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ONCOLOGY, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 70: NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ONCOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 71: EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ONCOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 72: ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR ONCOLOGY, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 73: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR HORMONAL IMBALANCE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 74: NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR HORMONAL IMBALANCE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 75: EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR HORMONAL IMBALANCE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 76: ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR HORMONAL IMBALANCE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 77: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR GLAUCOMA, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 78: NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR GLAUCOMA, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 79: EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR GLAUCOMA, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 80: ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR GLAUCOMA, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 81: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 82: NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 83: EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 84: ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 85: GLOBAL HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 86: NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 87: NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 88: NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 89: NORTH AMERICA: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 90: NORTH AMERICA: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 91: NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 92: NORTH AMERICA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 93: NORTH AMERICA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 94: NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 95: U.S.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 96: U.S.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 97: U.S.: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 98: U.S.: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 99: U.S.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 100: U.S.: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 101: U.S.: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 102: U.S.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 103: CANADA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 104: CANADA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 105: CANADA: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 106: CANADA: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 107: CANADA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 108: CANADA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 109: CANADA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 110: CANADA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 111: EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 112: EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 113: EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 114: EUROPE: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 115: EUROPE: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 116: EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 117: EUROPE: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 118: EUROPE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 119: EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 120: GERMANY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 121: GERMANY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 122: GERMANY: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 123: GERMANY: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 124: GERMANY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 125: GERMANY: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 126: GERMANY: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 127: GERMANY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 128: FRANCE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 129: FRANCE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 130: FRANCE: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 131: FRANCE: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 132: FRANCE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 133: FRANCE: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 134: FRANCE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 135: FRANCE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 136: U.K.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 137: U.K.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 138: U.K.: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 139: U.K.: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 140: U.K.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 141: U.K.: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 142: U.K.: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 143: U.K.: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 144: ITALY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 145: ITALY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 146: ITALY: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 147: ITALY: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 148: ITALY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 149: ITALY: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 150: ITALY: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 151: ITALY: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 152: SPAIN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 153: SPAIN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 154: SPAIN: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 155: SPAIN: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 156: SPAIN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 157: SPAIN: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 158: SPAIN: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 159: SPAIN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 160: ROE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 161: ROE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 162: ROE: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 163: ROE: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 164: ROE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 165: ROE: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 166: ROE: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 167: ROE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 168: ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 169: ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 170: ASIA: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 171: ASIA: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 172: ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 173: ASIA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 174: ASIA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 175: ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 176: JAPAN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 177: JAPAN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 178: JAPAN: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 179: JAPAN: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 180: JAPAN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 181: JAPAN: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 182: JAPAN: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 183: JAPAN: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 184: CHINA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 185: CHINA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 186: CHINA: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 187: CHINA: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 188: CHINA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 189: CHINA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 190: CHINA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 191: CHINA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 192: INDIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 193: INDIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 194: INDIA: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 195: INDIA: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 196: INDIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 197: INDIA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 198: INDIA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 199: INDIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 200: ROA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 201: ROA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 202: ROA: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 203: ROA: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 204: ROA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 205: ROA: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 206: ROA: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 207: ROA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 208: ROW: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 209: ROW: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2014-2021 (USD MILLION)
  • TABLE 210: ROW: MERCHANT MANUFACTURERS MARKET SIZE, BY HPAPI TYPE, 2014-2021 (USD MILLION)
  • TABLE 211: ROW: MERCHANT MANUFACTURERS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 212: ROW: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY MODE OF SYNTHESIS, 2014-2021 (USD MILLION)
  • TABLE 213: ROW: SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 214: ROW: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 215: ROW: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 216: AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND ALLIANCES (2013-2016)
  • TABLE 217: MERGERS AND ACQUISITIONS (2013-2016)
  • TABLE 218: REGULATORY APPROVALS (2013-2016)
  • TABLE 219: EXPANSIONS (2013-2016)
  • TABLE 220: EXCHANGE RATE (UTILIZED FOR THE CONVERSION OF EUR TO USD)
  • TABLE 221: EXCHANGE RATES (UTILIZED FOR THE CONVERSION OF CHF TO USD)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 3: MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
  • FIGURE 4: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5: DATA TRIANGULATION METHODOLOGY
  • FIGURE 6: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE, 2016 VS. 2021
  • FIGURE 7: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE, BY TYPE OF MANUFACTURER, 2016 VS. 2021
  • FIGURE 8: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE OF SYNTHESIS, 2016 VS. 2021
  • FIGURE 9: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION: ONCOLOGY SEGMENT TO DOMINATE THE MARKET IN 2016
  • FIGURE 10: GEOGRAPHIC SNAPSHOT OF THE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET
  • FIGURE 11: RISING NEED TO COMPLY WITH REGULATORY REQUIREMENTS, THE MAJOR FACTOR DRIVING THE GROWTH OF THE MARKET
  • FIGURE 12: INNOVATIVE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016
  • FIGURE 13: BIOTECH HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 14: ONCOLOGY SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: CHINA TO WITNESS HIGHEST GROWTH DURING 2012-2021
  • FIGURE 16: ACTIVE PHARMACEUTICAL INGREDIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SEGMENTATION, BY TYPE
  • FIGURE 18: INNOVATIVE SEGMENT TO DOMINATE THE ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY TYPE, IN 2016
  • FIGURE 19: SYNTHETIC SEGMENT TO DOMINATE THE MARKET IN 2016
  • FIGURE 20: NORTH AMERICA TO HOLD LARGEST SHARE IN THE SYNTHETIC HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET IN 2016
  • FIGURE 21: CAPTIVE MANUFACTURERS TO HOLD LARGEST SHARE OF THE MARKET IN 2016
  • FIGURE 22: NORTH AMERICA TO DOMINATE THE CAPTIVE MANUFACTURERS MARKET IN 2016
  • FIGURE 23: ONCOLOGY TO DOMINATE THE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, BY THERAPEUTIC APPLICATION (2016)
  • FIGURE 24: ASIA TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD (2016-2021)
  • FIGURE 25: NORTH AMERICA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT (2016)
  • FIGURE 26: EUROPE: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT
  • FIGURE 27: ASIA: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT
  • FIGURE 28: REST OF THE WORLD: HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SNAPSHOT
  • FIGURE 29: KEY DEVELOPMENTS IN THE HIGH-POTENCY ACTIVE PHARMACEUTICAL INGREDIENTS MARKET, 2013-2016
  • FIGURE 30: MARKET EVOLUTION FRAMEWORK- AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND ALLIANCES FUELED MARKET GROWTH
  • FIGURE 31: MARKET SHARE ANALYSIS: ONCOLOGY SEGMENT, BY KEY PLAYER, 2015
  • FIGURE 32: BATTLE FOR MARKET SHARE: AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND ALLIANCES WAS THE KEY STRATEGY ADOPTED BY MARKET PLAYERS (2013-2016)
  • FIGURE 33: GEOGRAPHIC MIX OF THE TOP 5 PLAYERS
  • FIGURE 34: PFIZER, INC.: COMPANY SNAPSHOT
  • FIGURE 35: NOVARTIS INTERNATIONAL AG: COMPANY SNAPSHOT
  • FIGURE 36: SANOFI: COMPANY SNAPSHOT
  • FIGURE 37: F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 38: BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT
  • FIGURE 39: BOEHRINGER INGELHEIM: COMPANY SNAPSHOT
  • FIGURE 40: TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT
  • FIGURE 41: ELI LILLY AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 42: MERCK & CO., INC.: COMPANY SNAPSHOT
  • FIGURE 43: ABBVIE INC.: COMPANY SNAPSHOT
  • FIGURE 44: MYLAN INC.: COMPANY SNAPSHOT
Back to Top